Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
This was the 1st sizable M&A deal of the #JPM25 news cycle—2 days ago Michigan-based medtech company Stryker announced plans to buy Irvine, CA-based Inari Medical in $4.9B deal. More below: #JPM2025 https://t.co/wstlKN3B2J
This was the 1st sizable M&A deal of the #JPM25 cycle—yesterday medtech company Stryker announced plans to buy Inari Medical in $4.9B deal. More below: #JPM2025 https://t.co/wstlKN3B2J
🫁Inari Medical $NARI's option volume has skyrocketed! Typically trading about 61 calls a day, it jumped to 450 in December. This week, it hit nearly 8000 calls! This surge clearly signals heightened interest. Today, Stryker $SKY steps in, eyeing this medical device innovator for… https://t.co/fqACyzb8CS
Stryker Corporation, a Michigan-based medical technology company, has announced its plans to acquire Inari Medical, an Irvine, California-based innovator in medical devices, for $4.9 billion. This acquisition marks the first sizable merger and acquisition deal of the 2025 JPMorgan Healthcare Conference cycle. Following the announcement, Inari Medical's option trading volume surged dramatically, jumping from an average of 61 calls per day to nearly 8,000 calls, indicating heightened investor interest in the company. The deal is expected to enhance Stryker's portfolio in the medical device sector.
